Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
Top Cited Papers
- 5 May 2009
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 373 (9676), 1673-1680
- https://doi.org/10.1016/s0140-6736(09)60734-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty SurgeryThe Journal of Arthroplasty, 2009
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip ArthroplastyNew England Journal of Medicine, 2008
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee ArthroplastyNew England Journal of Medicine, 2008
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trialThe Lancet, 2008
- Prevention of Venous ThromboembolismChest, 2008
- Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgeryBritish Journal of Surgery, 2005
- Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin for the Prevention of Venous Thromboembolism After Total Knee ArthroplastyThe Journal of Bone and Joint Surgery (American), 2005
- Preoperative or Postoperative Start of Prophylaxis for Venous Thromboembolism With Low-Molecular-Weight Heparin in Elective Hip Surgery?Archives of Internal Medicine, 2002
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryNew England Journal of Medicine, 2001
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972